Institute for Social medicine, Epidemiology & Health Economics
Berlin, State of Berlin, 10117, Germany
NCT Number: NCT00778648
The primary objective of this study is to determine the effect of an encapsulated juice powder concentrate on the number of days with at least moderate common cold symptoms over winter time.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Berlin, State of Berlin, 10117, Germany
Common cold is the most frequent acute illness in industrialised societies. Though it is usually benign, it is a leading cause of absence from work and doctor visits, causing an enormous economic burden including lost productivity and treatment costs.
Common cold is caused by a variety of viruses, with rhinoviruses and corona viruses as the most common. There is currently no treatment for common cold, thus therapy is focussed on symptom relief only. Prevention strategies for common cold include lifestyle measures such as avoiding infected people and regular hand washing during cold season. Dietary supplements including herbs and vitamins have been suggested as preventive strategies for common cold.
Juice Plus+® is a dietary supplement composed primarily of juice powder concentrate and pulp from fruits and vegetables. It contains several antioxidants including vitamin C, vitamin E, beta-carotene and folate. One randomized study reported reduction in work days lost to illness in the Juice Plus+® group compared to the placebo group. However, the clinical benefit for preventing common cold symptoms has not yet been tested in a large adult population.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Juice Plus+® is a dietary supplement from concentrated fruits (apple, orange, pineapple,cranberry, cherry (acerola), papaya and peach) and vegetables (carrot, parsley, beet, broccoli, kale, cabbage, spinach, and tomato).
Subjects will take four capsules of Juice Plus+® daily.
Other names: Juice Plus+®
Four capsules of placebo daily.
Time frame: within 6 months (after 2 months run-in period)
Time frame: Baseline, months 2,4,6,8.
Charite University, Berlin, Germany
Other
Effectiveness of an Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06724185
Common Cold, Immunity
Taichung, Taiwan
View Trial DetailsNCT00448981
Common Cold, Infections
New York, United States
View Trial DetailsNCT06716645
Common Cold, Cough
New York, United States
View Trial DetailsNCT06278324
Acute Respiratory Tract Infection, COVID-19
Dijon, Burgundy, France
View Trial Details